Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis

Standard cytotoxic chemotherapy for Hodgkin Lymphoma (HL) has changed little in 30 years; the treatment for patients with relapsed or refractory disease remains challenging and novel agents are under development. JAK/STAT constitutive activation plays an important role in the pathogenesis of HL. Les...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz, Tania, Navarro, Alfons, Ferrer, Gerardo, Gel, Bernat, Gaya, Anna, Artells, Rosa, Bellosillo, Beatriz, Garcia-Garcia, Mar, Serrano, Sergi, Martínez, Antonio, Monzo, Mariano
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080386/
https://www.ncbi.nlm.nih.gov/pubmed/21533094
http://dx.doi.org/10.1371/journal.pone.0018856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080386/
https://www.ncbi.nlm.nih.gov/pubmed/21533094
http://dx.doi.org/10.1371/journal.pone.0018856

Ejemplares similares